Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this
Click Therapeuticsclicktherapeutics.comClick Therapeutics develops prescription digital therapeutics that deliver software-based treatments to patients via smartphone, prescribed by physicians. Their Click SE platform combines software with pharmacotherapy to create Software-Enhanced Drugs (SEDs) intended to provide added clinical benefit over drugs alone. They validate and commercialize digital treatments across multiple diseases, including FDA-cleared products such as CT-152 (Rejoyn).
Parse Score
Sources
clicktherapeutics.com shapes more of what AI says about Click Therapeutics than any other source, at 63% of its citations.
clinicaltrials.gov · apps.apple.com · biospace.com · diatribe.org
Excerpts where Click Therapeutics appeared in the AI's answer
Click Therapeutics developed Clickotine , a digital therapeutic that delivers a personalized program adhering to the US Clinical Practice Guidelines (USCPG).
Click Therapeutics has evaluated Clickotine in multiple clinical trials
